• Chen, G., and Davies, M.A. (2012). Emerging Insights into the molecular biology of brain metastases. Biochem. Pharmacol. 83, 305314.
  • Cruz-Munoz, W., Man, S., Xu, P., and Kerbel, R.S. (2008). Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res. 68, 45004505.
  • Davies, M.A., Liu, P., McIntyre, S., Kim, K.B., Papadopoulos, N., Hwu, W.J., Hwu, P., and Bedikian, A. (2011). Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117, 16871696.
  • Eichler, A.F., and Loeffler, J.S. (2007). Multidisciplinary management of brain metastases. Oncologist 12, 884898.
  • Elliott, R.E., Rush, S.C., Morsi, A., Mehta, N., Spriet, J., Narayana, A., Donahue, B., Parker, E.C., and Golfinos, J.G. (2011). Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 gy) gamma knife radiosurgery. Neurosurgery 68, 921931.
  • Fujimaki, T., Price, J.E., Fan, D., Bucana, C.D., Itoh, K., Kirino, T., and Fidler, I.J. (1996). Selective growth of human melanoma cells in the brain parenchyma of nude mice. Melanoma Res. 6, 363371.
  • Gaviani, P., Mullins, M.E., Braga, T.A., Hedley-Whyte, E.T., Halpern, E.F., Schaefer, P.S., and Henson, J.W. (2006). Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am. J. Neuroradiol. 27, 605608.
  • Huang, F.J., Steeg, P.S., Price, J.E., Chiu, W.T., Chou, P.C., Xie, K., Sawaya, R., and Huang, S. (2008). Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res. 68, 96349642.
  • Isiklar, I., Leeds, N.E., Fuller, G.N., and Kumar, A.J. (1995). Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. Am. J. Roentgenol. 165, 15031512.
  • Izraely, S., Sagi-Assif, O., Klein, A., et al. (2012). The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int. J. Cancer 131, 10711082.
  • Johnson, J.D., and Young, B. (1996). Demographics of brain metastasis. Neurosurg. Clin. N. Am. 7, 337344.
  • Perera, M., Ribot, E.J., Percy, D.B., McFadden, C., Simedrea, C., Palmieri, D., Chambers, A.F., and Foster, P.J. (2012). In Vivo Magnetic Resonance Imaging for Investigating the Development and Distribution of Experimental Brain Metastases due to Breast Cancer. Transl. Oncol. 5, 217225.
  • Rush, S., Elliott, R.E., Morsi, A., Mehta, N., Spriet, J., Narayana, A., Donahue, B., Parker, E.C., and Golfinos, J.G. (2011). Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy. J. Neurosurg. 115, 3748.
  • Sampson, J.H., Carter, J.H., Jr., Friedman, A.H., and Seigler, H.F. (1998). Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J. Neurosurg. 88, 1120.
  • Scholtzova, H., Wadghiri, Y.Z., Douadi, M., Sigurdsson, E.M., Li, Y.S., Quartermain, D., Banerjee, P., and Wisniewski, T. (2008). Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice as shown by micromagnetic resonance imaging. J. Neurosci. Res. 86, 27842791.
  • Xie, T.X., Huang, F.J., Aldape, K.D., Kang, S.H., Liu, M., Gershenwald, J.E., Xie, K., Sawaya, R., and Huang, S. (2006). Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 66, 31883196.
  • Yano, S., Shinohara, H., Herbst, R.S., Kuniyasu, H., Bucana, C.D., Ellis, L.M., Davis, D.W., McConkey, D.J., and Fidler, I.J. (2000). Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res. 60, 49594967.
  • Zhang, C., Zhang, F., Tsan, R., and Fidler, I.J. (2009). Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. Cancer Res. 69, 828835.